CROs and Sponsors

Our clinical trials network

Fusion Clinical Research works with local and international contract research organisations and sponsors including pharmaceutical, biotech, digital health and medical device companies to provide GPs and other health care professionals opportunities to run clinical trials in urban and regional clinics for their patients.

Our network sites are community practices and include general practices (GPs) and specialist practices, ranging from arthritis, cancer to diabetes, dermatology and more. Our network provides access to a rich database of patients and with high participation due to the vicinity of the clinical site to a patient's home and continuity of care.

We understand that the success of clinical research relies on safe and reliable recruitment and we have a consistent GP practice targeted approach.

Our partnerships begin at the feasibility and start-up phase, at which time our engagement team liaises with the GP practice team to review our vast patient database and to map out a successful path forward for all clinical partners. If trial capacity is not immediately available, a bespoke network for a study can be created.

Every trial is individually reviewed utilising a GP-led focus group and employing tailored strategies, including direct primary health care liaisons, GP and practice nurse referrals, GP practice advertising and targeted social media applications.

Fusion Clinical Research is a division of CMAX Clinical Research. We have experienced study teams at our sites, who operate with a detailed set of SOPs and work instructions under the governance of the CMAX Clinical Research Quality Management team. We maintain the highest of quality standards to ensure our Sponsor’s experience a best practice delivery of their trial at sites within our network.

I'rom Group contributes to medical development through four business pillars:

  1. Advanced Medicinal Treatment Services
  2. Site Management Organisation (SMO) Services
  3. Contract Research Organisation (CRO)
  4. Services and Medical Support Services

The company’s philosophy is "Moving forward with the goal of building tomorrow’s healthcare."

Are you interested in partnering with Fusion Clinical Research to conduct a clinical trial?

Send us an enquiry

  • :

Our expertise

We are based in the medical hub of central Adelaide, adjacent to the Royal Adelaide Hospital and The South Australian Health and Medical Research Institute (SAHMRI), home to more than 700 medical researchers working together to tackle the biggest health challenges in society today.

Australia is home to some of the world's best researchers and health professionals and boasts a world-class research infrastructure, a stable socio-political environment, and high standards that ensure confidence in the scientific conclusions reached by clinical trials conducted in Australia.

Australia has an efficient regulatory pathway for clinical trials. Under the Clinical Trials Notification (CTN) scheme administered by the Therapeutic Goods Administration (TGA), research proposals are submitted directly to Australian Human Research Ethics Committees (HRECs) which assume the primary review responsibility for ethical and scientific review. The usual review cycle takes only 4 to 8 weeks.

The Australian Government’s generous Research & Development (R&D) tax incentive encourages investment in medical R&D. The Incentive provides for increased access by international companies. In particular, there is no requirement to hold the intellectual property in Australia. Increased level of expenditure that can be claimed on R&D activities undertaken overseas in support of Australian R&D projects, under certain conditions.

Above all, the new system provides a globally competitive tax incentive for conducting R&D activities in Australia. More information about the R&D Tax Incentive can be found at

Our experienced team comprises nurses, scientists and technicians who are practised in client services and patient care; trial start-up activities and trial execution with access to a broad patient population through an extensive GP and specialist clinic network. Fusion Clinical Trials studies are supported by trusted and tested CMAX Clinical Research systems and processes.